Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Montagu Newhall Global Partners, which later rebranded as Greenspring Associates, was a prominent venture capital firm that managed a diversified investment platform including fund-of-funds, direct venture capital investments, and secondary market transactions. The firm maintained a significant focus on the healthcare and life sciences sectors, providing essential growth capital to innovative biotechnology, medical technology, and digital health companies. Founded in 2000 and headquartered in Maryland, the firm grew to manage billions in assets before its eventual acquisition. In 2021, the firm was acquired by StepStone Group for approximately $780 million to integrate its venture capital expertise into StepStone's global private markets platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Montagu Newhall Global Partners.